These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3600907)

  • 1. Colchicine reduces proteinuria in passive Heymann nephritis.
    Milner LS; Lotan D; Mills M; Goodyer PR; Fong JS; Kaplan BS
    Nephron; 1987; 46(1):11-7. PubMed ID: 3600907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of protein excretion by dimethyl sulfoxide in rats with passive Heymann nephritis.
    Lotan D; Kaplan BS; Fong JS; Goodyer PR; de Chadarevian JP
    Kidney Int; 1984 May; 25(5):778-88. PubMed ID: 6471664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions of dimethyl sulfoxide and nonsteroidal anti-inflammatory agents in passive Heymann's nephritis.
    Kaplan BS; Milner LS; Lotan D; Mills M; Goodyer PR; Fong JS
    J Lab Clin Med; 1986 May; 107(5):425-30. PubMed ID: 2939160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolytic enzyme treatment reduces glomerular immune deposits and proteinuria in passive Heymann nephritis.
    Nakazawa M; Emancipator SN; Lamm ME
    J Exp Med; 1986 Dec; 164(6):1973-87. PubMed ID: 3537193
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of cyclooxygenases reduces complement-induced glomerular epithelial cell injury and proteinuria in passive Heymann nephritis.
    Takano T; Cybulsky AV; Cupples WA; Ajikobi DO; Papillon J; Aoudjit L
    J Pharmacol Exp Ther; 2003 Apr; 305(1):240-9. PubMed ID: 12649375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indomethacin reduces proteinuria in passive Heymann nephritis in rats.
    Zoja C; Benigni A; Verroust P; Ronco P; Bertani T; Remuzzi G
    Kidney Int; 1987 Jun; 31(6):1335-43. PubMed ID: 2956450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of flosulide, a selective cyclooxygenase 2 inhibitor, on passive heymann nephritis in the rat.
    Blume C; Heise G; Mühlfeld A; Bach D; Schrör K; Gerhardz CD; Grabensee B; Heering P
    Kidney Int; 1999 Nov; 56(5):1770-8. PubMed ID: 10571785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Passive Heymann nephritis: evidence that angiotensin-converting enzyme inhibition reduces proteinuria and retards renal structural injury.
    Zoja C; Corna D; Bruzzi I; Foglieni C; Bertani T; Remuzzi G; Benigni A
    Exp Nephrol; 1996; 4(4):213-21. PubMed ID: 8983642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of combining ACE inhibitor and statin in severe experimental nephropathy.
    Zoja C; Corna D; Rottoli D; Cattaneo D; Zanchi C; Tomasoni S; Abbate M; Remuzzi G
    Kidney Int; 2002 May; 61(5):1635-45. PubMed ID: 11967013
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement and monocytes are essential for provoking glomerular injury in passive Heymann nephritis in rats. Terminal complement components are not the sole mediators of proteinuria.
    Hara M; Batsford SR; Mihatsch MJ; Bitter-Suermann D; Vogt A
    Lab Invest; 1991 Aug; 65(2):168-79. PubMed ID: 1881120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new role for complement in experimental membranous nephropathy in rats.
    Salant DJ; Belok S; Madaio MP; Couser WG
    J Clin Invest; 1980 Dec; 66(6):1339-50. PubMed ID: 7440718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining lisinopril and l-arginine slows disease progression and reduces endothelin-1 in passive Heymann nephritis.
    Zoja C; Benigni A; Camozzi D; Corna D; Longaretti L; Todeschini M; Remuzzi G
    Kidney Int; 2003 Sep; 64(3):857-63. PubMed ID: 12911535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on antinephritic effect of TJ-8014, a new Japanese herbal medicine (4): Effects on accelerated passive Heymann nephritis in rats.
    Hattori T; Ito M; Suzuki Y
    Jpn J Pharmacol; 1990 Nov; 54(3):265-75. PubMed ID: 1708836
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor antagonists of platelet-activating factor do not influence the development of passive Heymann nephritis.
    Salvidio G; Brentjens J; Camussi G
    J Lipid Mediat; 1991; 3(2):197-204. PubMed ID: 1665716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerular charge barrier and development of proteinuria in passive Heymann nephritis.
    Christiansen RE; Kolmannskog O; Leh S; Iversen BM; Tenstad O
    Kidney Blood Press Res; 2008; 31(3):203-9. PubMed ID: 18544954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultrastructural background of albuminuria in rats with passive Heymann nephritis.
    Arai T; Morimoto K; Masaoka H; Kaneko O; Mera J; Kojima K; Nagase M; Kobayashi S; Ohtake T; Hishida A
    Nephrol Dial Transplant; 1997 Dec; 12(12):2542-8. PubMed ID: 9430849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential capacity of anti-RAP and anti-megalin antibodies to produce progressive passive Heymann nephritis - implications for the pathogenesis of idiopathic human membranous glomerulonephritis.
    Makker SP; Tramontano A
    J Pathol; 2006 Nov; 210(3):282-7. PubMed ID: 16981232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different effect of cyclosporine A and mycophenolate mofetil on passive Heymann nephritis in the rat.
    Blume C; Heise G; Hess A; Waldner C; Grabensee B; Schroer K; Heering P
    Nephron Exp Nephrol; 2005; 100(2):e104-12. PubMed ID: 15855806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The long-term evolution of immune deposits in passive Heymann nephritis.
    Soares VA; Almeida DB
    Braz J Med Biol Res; 1992; 25(2):149-59. PubMed ID: 1339511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beneficial effects of colchicine in experimental nephrotoxic serum nephritis in the rat.
    Penchas S; Charuzi I; Boss JH
    Eur J Clin Invest; 1979 Apr; 9(2 Pt 1):161-6. PubMed ID: 111949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.